Description
Soliqua Solostar Pens, infused with insulin glargine and lixisenatide, offer an advanced solution for adults battling type 2 diabetes mellitus. When paired with a balanced diet and consistent exercise, they optimize blood glucose control. These pens facilitate the subcutaneous delivery of both insulin glargine—a long-acting human insulin analog that takes effect hours post-injection—and lixisenatide, an agent that boosts insulin production in the pancreas.